2022/2785(RSP) Resolution on Commission Implementing Regulation (EU) 2022/1480 of 7 September 2022 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bensulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, esfenvalerate, etofenprox, fenoxaprop-P, fenpropidin, fenpyrazamine, fludioxonil, flufenacet, flumetralin, fosthiazate, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, prohexadione, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulphur, tebufenpyrad, tetraconazole, tri-allate, triflusulfuron and tritosulfuron
Lead committee dossier:
Progress: Procedure completed
Role | Committee | Rapporteur | Shadows |
---|---|---|---|
Lead | ENVI | ARENA Maria ( S&D), METZ Tilly ( Verts/ALE), HAZEKAMP Anja ( GUE/NGL) |
Lead committee dossier:
Legal Basis:
RoP 112-p2
Legal Basis:
RoP 112-p2Events
2022/10/18
EP - Text adopted by Parliament, single reading
Documents
2022/10/18
EP - Decision by Parliament
Documents
2022/10/10
EP - Motion for a resolution
Documents
2022/07/13
EP - ARENA Maria (S&D) appointed as rapporteur in ENVI
2022/07/13
EP - METZ Tilly (Verts/ALE) appointed as rapporteur in ENVI
2022/07/13
EP - HAZEKAMP Anja (GUE/NGL) appointed as rapporteur in ENVI
Documents
- Text adopted by Parliament, single reading: T9-0363/2022
- Decision by Parliament: T9-0363/2022
- Motion for a resolution: B9-0460/2022
- Motion for a resolution: B9-0460/2022
- Text adopted by Parliament, single reading: T9-0363/2022
Activities
Votes
Objection conformément à l’article 112, paragraphes 2 et 3, du règlement: substances actives, y compris l’hydroxy-8-quinoléine, le chlorotoluron et le difénoconazole - Objection pursuant to Rule 112 (2) and (3): Active substances, including 8-hydroxyquinoline, chlorotoluron and difenoconazole - Einwand gemäß Artikel 112 Absätze 2 und 3 GO: Wirkstoffe, darunter 8-Hydroxychinolin, Chlortoluron und Difenoconazol - B9-0460/2022 - Proposition de résolution #
2022/10/18 Outcome: +: 349, -: 275, 0: 14
History
(these mark the time of scraping, not the official date of the change)
2023-08-03Show (6) Changes | Timetravel
docs/1 |
|
docs/1 |
|
events/0 |
|
events/0 |
|
events/1 |
|
events/1/summary |
|
2022-10-22Show (5) Changes
docs/1 |
|
events |
|
forecasts |
|
procedure/stage_reached |
Old
Awaiting plenary debate/voteNew
Procedure completed |
procedure/title |
Old
Objection pursuant to Rule 112(2) and (3) extending the approval period of 8-hydroxyquinolineNew
Resolution on Commission Implementing Regulation (EU) 2022/1480 of 7 September 2022 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances 2-phenylphenol (including its salts such as the sodium salt), 8-hydroxyquinoline, amidosulfuron, bensulfuron, bifenox, chlormequat, chlorotoluron, clofentezine, clomazone, daminozide, deltamethrin, dicamba, difenoconazole, diflufenican, dimethachlor, esfenvalerate, etofenprox, fenoxaprop-P, fenpropidin, fenpyrazamine, fludioxonil, flufenacet, flumetralin, fosthiazate, lenacil, MCPA, MCPB, nicosulfuron, paraffin oils, paraffin oil, penconazole, picloram, prohexadione, propaquizafop, prosulfocarb, quizalofop-P-ethyl, quizalofop-P-tefuryl, sodium 5-nitroguaiacolate, sodium o-nitrophenolate, sodium p-nitrophenolate, sulphur, tebufenpyrad, tetraconazole, tri-allate, triflusulfuron and tritosulfuron |